A first in the history of cancer: A miracle antibody cures all patients

Written by jeunes

An experimental cancer drug appears to have cured all patients in a clinical trial in the United States. Dostarlimab is a monoclonal antibody that likely completely eliminated colorectal cancer in the patients involved in this trial.
During a clinical trial, all patients treated for non-metastatic rectal cancer with dostarlimab, an immunotherapy monoclonal antibody produced by a biotech acquired by the giant GSK, are in remission six to twenty-five months later. the treatment. With much better tolerance than the standard treatment based on radiochemotherapy and surgery.
“I believe this is the first time this has happened in the history of cancer.” Doctor Luis A. Diaz Jr, of Memorial Sloan Kettering Cancer Center does not hide his enthusiasm after the results obtained during this clinical trial.
With other doctors, he has just published an article in the reference medical journal New England Journal of Medicine on a clinical trial conducted with a dozen patients with colorectal cancer in the United States.

Laissez un commentaire

This site uses Akismet to reduce spam. Learn how your comment data is processed.